Maryland firm announced birth of rhFVII transgenic rabbits at Chinese subsidiary. Pharming inked a service agreement with Renova Life through which the latter will develop founder transgenic rabbits ...

In late 2010, PharmAthene closed the site where it had made the recombinant enzyme Protexia in the milk of transgenic animals. Government support for the nerve agent countermeasure had waned because ...

Building for transgenic rabbits is the first of its kind to receive this approval. Pharming reports that its facilities for the manufacturing of Rhucin® have successfully passed the EMEA’s inspections ...

A few days ago Pharming announced plans for a Phase IIIb study of Rhucin, an experimental therapy produced in transgenic rabbits, in anticipation of running into fresh regulatory challenges. And it ...

The small but growing field of transgenic drug development took another step forward today with the announcement that Dutch biotech company Pharming has received the FDA's orphan drug status for an ...

Sovacool is a graduate research assistant at the Center for Science & Technology Studies at Virginia Tech. A recent symposium on the legal and social implications of genetic engineering held at ...

LONDON, July 13 (Reuters) - Dutch biotechnology company Pharming has won a green light for its drugmaking facilities, boosting prospects for the group's rabbit milk-derived drug Rhucin, its most ...